Heart failure (HF) remains a significant cardiovascular public health concern in India, affecting an estimated 1.3 to 22.7 ...

A new study published in the European Journal of Medical Research revealed that dapagliflozin, a sodium-glucose ...

US-based Cardurion Pharmaceuticals has completed enrolment in two multi-centre, global Phase II CYCLE trials of the ...

There is lower risk for recurrent HF hospitalization in older patients that receive SGLT2is following acute decompensated heart failure.

Rayan Salih, MD, a third-year internal medicine resident with the Northeast Georgia Health System, who hopes to specialize in cardiology, presented the poster, “Double Trouble: Pregnancy Challenges in ...

Dapagliflozin-spironolactone reduces NT-proBNP levels and blood pressure more than dapagliflozin alone but at the cost of a ...

Left bundle branch block may serve as an important indicator for asymptomatic individuals predisposed to heart failure.

Ultromics has raised $55 million in venture capital funding to expand the reach of its artificial-intelligence-powered ...

A tiny implantable heart device is changing lives for patients with HFpEF heart failure. Scripps La Jolla is among 65 ...

For the HF patient with a gain in LVEF, there’s little guidance on how best to care for them or manage their GDMT.

Novo Nordisk (($DE:NOVA)) announced an update on their ongoing clinical study. Novo Nordisk is conducting a Phase 2 study titled ‘A Research Study ...

Discover how tirzepatide benefits heart failure in obesity, and see why those with higher BMI may gain even more benefits.